Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Gross

Showing results (141-150 of 263) with videos related to

Pageof 27
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|September 26, 2012
Vitamin D status in HIV-infected patients with and without tuberculosis: a pilot studyAndrew P Steenhoff, Abiona Redwood, John M Pettifor, et al.
JCO Global Oncology|May 18, 2022
Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant ChemotherapyYehoda M Martei, Mohan Narasimhamurthy, Dipho I Setlhako, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 4, 2008
Slow efavirenz metabolism genotype is common in BotswanaRobert Gross, Richard Aplenc, Thomas Tenhave, et al.
Plos One|March 6, 2008
Overestimates of survival after HAART: implications for global scale-up effortsGregory P Bisson, Tendani Gaolathe, Robert Gross, et al.
Infectious Disorders Drug Targets|March 17, 2011
HIV treatment adherence, drug resistance, virologic failure: evolving conceptsJean B Nachega, Vincent C Marconi, Gert U van Zyl, et al.
Southern African Journal of HIV Medicine|July 17, 2020
Feasibility of implementing a novel behavioural smoking cessation intervention amongst human immunodeficiency virus-infected smokers in a resource-limited setting: A single-arm pilot trialBilly M Tsima, Precious Moedi, Joyce Maunge, et al.
AIDS Patient Care and Stds|November 17, 2021
Participants Switching to Second-Line Antiretroviral Therapy with Susceptible Virus Display Inferior Adherence and Worse Outcomes: An Observational AnalysisLentlametse Mantshonyane, Jason Roy, Michael Z Levy, et al.
European Journal of Drug Metabolism and Pharmacokinetics|September 1, 2018
Impact of Efavirenz Metabolism on Loss to Care in Older HIV+ AfricansJessie Torgersen, Scarlett L Bellamy, Bakgaki Ratshaa, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|July 12, 2008
Untreated hypertension and the emergency department: a chance to intervene?Craig A Umscheid, Maureen G Maguire, Jesse M Pines, et al.
The Lancet. Infectious Diseases|February 13, 2015
Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort studyShruthi Ravimohan, Neo Tamuhla, Andrew P Steenhoff, et al.
Pageof 27

Showing results (141-150 of 263) with videos related to

Sort By:
Pageof 27
Journal of Acquired Immune Deficiency Syndromes (1999)|September 26, 2012
Vitamin D status in HIV-infected patients with and without tuberculosis: a pilot studyAndrew P Steenhoff, Abiona Redwood, John M Pettifor, et al.
JCO Global Oncology|May 18, 2022
Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant ChemotherapyYehoda M Martei, Mohan Narasimhamurthy, Dipho I Setlhako, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 4, 2008
Slow efavirenz metabolism genotype is common in BotswanaRobert Gross, Richard Aplenc, Thomas Tenhave, et al.
Plos One|March 6, 2008
Overestimates of survival after HAART: implications for global scale-up effortsGregory P Bisson, Tendani Gaolathe, Robert Gross, et al.
Infectious Disorders Drug Targets|March 17, 2011
HIV treatment adherence, drug resistance, virologic failure: evolving conceptsJean B Nachega, Vincent C Marconi, Gert U van Zyl, et al.
Southern African Journal of HIV Medicine|July 17, 2020
Feasibility of implementing a novel behavioural smoking cessation intervention amongst human immunodeficiency virus-infected smokers in a resource-limited setting: A single-arm pilot trialBilly M Tsima, Precious Moedi, Joyce Maunge, et al.
AIDS Patient Care and Stds|November 17, 2021
Participants Switching to Second-Line Antiretroviral Therapy with Susceptible Virus Display Inferior Adherence and Worse Outcomes: An Observational AnalysisLentlametse Mantshonyane, Jason Roy, Michael Z Levy, et al.
European Journal of Drug Metabolism and Pharmacokinetics|September 1, 2018
Impact of Efavirenz Metabolism on Loss to Care in Older HIV+ AfricansJessie Torgersen, Scarlett L Bellamy, Bakgaki Ratshaa, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|July 12, 2008
Untreated hypertension and the emergency department: a chance to intervene?Craig A Umscheid, Maureen G Maguire, Jesse M Pines, et al.
The Lancet. Infectious Diseases|February 13, 2015
Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort studyShruthi Ravimohan, Neo Tamuhla, Andrew P Steenhoff, et al.
Pageof 27